Help us: Donate
Follow us on:

Novo Biosciences

Organization Description


Novo Biosciences have identified the first drug candidate shown to stimulate a damaged heart to repair itself by spurring regeneration in the cells so that the organ repairs itself like it did during development and like organs such as the liver do.


Kevin Strange, Ph.D.

Novo Biosciences - CEO

Want the latest longevity news? Subscribe to our Newsletter!